Is Pacific Biosciences of California (PACB) Stock a Buy For 2021?
Baron Discovery Fund recently published its fourth-quarter commentary – a copy of which can be downloaded here. During the fourth quarter of 2020, the Baron Discovery Fund returned 25.54% (institutional shares). This was 4.07% lower than the Russell 2000 Growth Index, the Fund’s primary benchmark index. You should check out Baron Discovery Fund’s top 5 stock picks for investors to buy right now, which could be the biggest winners of 2021.
In the Q4 2020 Investor Letter, Baron Discovery Fund highlighted a few stocks and Pacific Biosciences Of California Inc. (NASDAQ:PACB) is one of them. Pacific Biosciences Of California Inc. (NASDAQ:PACB) is a biotechnology company. In the last three months, Pacific Biosciences Of California Inc. (NASDAQ:PACB) stock gained 182% and on February 1st it had a closing price of $34.18. Here is what Baron Discovery Fund said:
Attractive Valuations Projected for Amgen Inc. (AMGN)
Distillate Capital, an employee-owned investment management firm, published its fourth-quarter 2020 Investor Letter – a copy of which can be downloaded here. A return of 19.22% was recorded by the fund for the Q4 of 2020, above both its S&P 500 benchmark that returned 18.4% and the Russell 1000 Value ETF that delivered a 2.67% return. You can view the fund’s top 10 holdings to have a peek at their top bets for 2021.
Distillate Capital, in their Q4 2020 Investor Letter said that they are optimistic in Amgen Inc. (NASDAQ: AMGN), and that they acquired a position in the company. Amgen Inc. is a premier world-class biotechnology company that currently has a $150.5 billion market cap. For the past 3 months, AMGN delivered a decent 19.51% return and settled at $258.60 per share at the closing of January 26th.
Is Avid Bioservices (CDMO) Stock a Buy For 2021?
Laughing Water Capital recently released its Q4 2020 Investor Letter, a copy of which you can download here. The fund posted a return of 28.2% for the quarter (net of fees), outperforming their benchmark, the S&P 500 Index which returned 12.2% in the same quarter. You should check out Laughing Water Capital’s top 5 stock picks for investors to buy right now, which could be the biggest winners of this year.
In the Q4 2020 Investor Letter, Laughing Water Capital highlighted a few stocks and Avid Bioservices Inc. (NASDAQ:CDMO) is one of them. Avid Bioservices Inc. (NASDAQ:CDMO) is a biotechnology company. In the last three months, Avid Bioservices Inc. (NASDAQ:CDMO) stock gained 81.7% and on January 25th it had a closing price of $14.70. Here is what Laughing Water Capital said: